MEREO BIOPHARMA GROUP PLC (MREO) Return on equity 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-102.4%FY2025 · since FY2022: -82.1% → -102.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -102.4% | -31.4 pp |
| FY2024 | -70.9% | -12.6 pp |
| FY2023 | -58.3% | +23.8 pp |
| FY2022 | -82.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice